https://www.dailymail.co.uk/health/article-8355273/WHO-says-SUSPENDING-trial-anti-malaria-drug-hydoxychloroquine-coronavirus-patients.html
WHO says it is SUSPENDING its trial of anti-malaria drug hydoxychloroquine in coronavirus patients citing safety concerns - a day after Trump boasts about finishing his prescription
A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns.
Hydroxychloroquine has been touted by President Donald Trump and he even revealed he took the medication for two weeks as a prophylactic.
But the World Health Organization (WHO) said it was concerned after a study from The Lancet published on Friday revealed higher mortality rates among COVID-19 patients who took the drug.
Therefore, researchers said they're suspending use of hydroxychloroquine in the WHO's Solidarity Trial, which is to evaluate the safety and efficacy of four drugs and drug combinations against the virus.
'The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,' WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
However, other arms of the trial are continuing, including testing of the experimental drug remdesivir and an HIV combination therapy.